Aortic Stents Graft Market Opportunity & Forecast 2033

Aortic Stents Grafts Market Outlook for 2023 to 2033

The aortic stents grafts market size is anticipated to be worth US$ 2.5 billion in 2023. The market is assumed to surge at a CAGR of 5% during the forecast period and, reach US$ 4.2 billion by 2033.

Key Market Trends and Highlights

Aortic stents grafts have witnessed a shift toward minimally invasive procedures, displacing traditional open surgeries. Patients and healthcare providers increasingly favor these less invasive techniques.
Continuous innovation is driving the aortic stents graft market. Improved designs, materials, and customization options are enhancing device safety and efficacy.
Emerging markets are experiencing a surge in demand for aortic stents grafts as healthcare infrastructure improves, and awareness grows. In established markets, leading players acquire innovative startups to expand their product portfolio and global reach.
Stringent regulatory processes for device approval and varying reimbursement policies create complexities in the market. Companies must navigate these hurdles while ensuring compliance, which can impact market penetration and adoption rates.

Attributes	Key Insights
Aortic Stents Grafts Market Size in 2023	US$ 2.5 billion
Projected Market Value in 2033	US$ 4.2 billion
Value-based CAGR from 2023 to 2033	5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

The scope for aortic stents grafts rose at a 4% CAGR between 2018 and 2022. The global market for aortic stents grafts is anticipated to expand at a moderate CAGR of 5% from 2023 to 2033.

Report Attributes	Details
Market Value in 2018	US$ 2.06 billion
Market Value in 2022	US$ 2.5 billion
CAGR from 2018 to 2022	4%

A rising incidence of aneurysm, expanding elderly population, poor lifestyle, and rising adoption of endovascular repair are boosting the aortic stents grafts industry, as reported by FMI analysts.

Endovascular repair has evolved as a routine treatment for those experiencing abdominal aortic aneurysms, and a substitute for patients who do not meet the criteria for open surgery.

Mounting aortic aneurysm (AA) cases around the globe is propelling the global aortic stents grafts sector. An estimated 167,249 deaths owing to aortic aneurysm (AA) were reported in 2017 globally, based on a paper released by the National Library of Medicine (LHM).

The rising popularity of testing techniques for early detection of aneurysms, combined with a growing elderly male population, is fueling the aortic stents grafts market. As aneurysm problems including AAA are asymptomatic, early detection might avert rupture and allow professionals to begin the right treatment approach.

The rising incidences of clinical trials and ongoing innovation in stents graft designs for improved endovascular aneurysm repair are expected to stimulate the aortic stents grafts market.

Aortic Stents Grafts Market Key Drivers

The global aging demographic is a significant driver. Aortic diseases, such as aneurysms, are prevalent among old individuals. As the population ages, the demand for aortic stents grafts is expected to rise.
Lifestyle-related risk factors such as smoking and hypertension contribute to the increasing incidence of aortic diseases. The prevalence of these risk factors further drives the demand for aortic stents grafts.
Aortic stents grafts offer minimally invasive treatment options, reducing patient trauma and post-operative recovery time. As patient preferences shift toward less invasive procedures, the demand for these devices increases.
Continuous innovation in aortic stents graft design, materials, and delivery systems enhances their safety and effectiveness. Advancements like fenestrated and branched stents grafts expand the treatable patient population, further driving market growth.
Emerging markets are witnessing improved healthcare infrastructure, leading to increased access to advanced medical devices like aortic stents grafts. This growth potential in developing regions is a significant market driver, as many patients gain access to treatment options.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Aortic Stents Grafts Market

Stringent regulatory processes and requirements for obtaining approvals and certifications can significantly delay product launches and increase development costs. Manufacturers must navigate complex regulatory pathways in different regions, which can be time-consuming and costly.
Varying reimbursement policies and rates across different healthcare systems and regions create challenges for market penetration. Inconsistents reimbursement can limit patient access to aortic stents grafts and affect product adoption rates.
The aortic stents graft market is highly competitive, with several established players and new entrants. Intense competition can lead to pricing pressure, potentially impacting profit margins. Companies must balance the need for competitive pricing with the need for sustainable revenue growth.

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and Germany. These two countries are expected to lead the market through 2033, with market values of US$ 730 million and US$ 600 million.

Expected Market Values in 2033

The United States	US$ 730 million
China	US$ 512 million
The United Kingdom	US$ 510 million
Japan	US$ 220 million
Germany	US$ 600 million

Forecast CAGRs from 2023 to 2033

The United States	5.3%
China	5%
The United Kingdom	4.9%
Japan	4.5%
Germany	5.1%

Substantial Demand for Minimally Invasive Procedures to Drive the United States Market

The United States is expected to reach US$ 730 million by 2033, rising at a CAGR of 5.3%. A few factors that contribute to the development of the country are

The high inclination for minimally invasive operations
The existence of favorable reimbursement regulations
The great frequency of smoking habits
The rising prevalence of aortic aneurysm

Based on the Centers for Disease Control and Prevention (CDC), around 9,904 people died in the United States in 2019 as an outcome of an aortic aneurysm or aortic dissection. A smoking history was found in around 75 percent of the total abdominal aortic aneurysms.

Several government and commercial organizations are lobbying for better screening in the face of increased mortality rates from abdominal aortic aneurysms. For example,

The United States Preventive Services Task Force recommends that males aged 65 to 75 years old who previously smoked acquire an ultrasound testing for abdominal aortic aneurysms, even if they have no indications.

Expanding Patient Pool to Play Key Role in the United Kingdom Market

Aortic stents graft trends in the United Kingdom are taking a turn for the better. A 4.9% CAGR is forecasted for the country from 2023 to 2033. By the end of this forecast period, the aortic stents grafts market in the United Kingdom is likely to total US$ 510 million.

The growing male senior population, and an increasing patient population affected by aortic aneurysms along with other cardiac disorders. According to the British Society of Interventional Radiology (BSIR), around 4% (nearly 80000) of men from 65 to 74 in England develop an abdominal aortic aneurysm (AAA). Around 6000 people die from AAA each year in England and Wales.

A substantial number of endovascular treatment procedures are conducted in the United Kingdom each year to address the aneurysm burden. This has resulted in a surge in market demand for aortic stents transplant items.

Rising Population Size Bolsters the Market in China

The aortic stents grafts market in China is expected to reach a value of US$ 512 million. The market in China is poised to expand at a CAGR of 5% through 2033.

The country's market is primarily driven by a fast-rising population size, an increase in the occurrence of aortic aneurysms, and a growing desire for less invasive operations.

China is becoming a desirable location for medical tourists with aneurysms owing to its expanding medical system and rapid development of novel medical gadgets at lower costs. Endovascular aneurysm repair (EVAR) operations are quite inexpensive in China. Aortic stents graft sales are increasing significantly.

Prominent medical equipment makers in China are attempting to expand their revenues by entering lucrative areas. This is expected to propel the development of the aortic stents grafts market throughout the forecast period. According to our analysts, Asia Pacific Excluding Japan (APEJ) had an industry share of 12% in 2022, with China dominating the way.

Demographic Shift Aids the Market in Japan

Expected to reach US$ 220 million by 2033, the aortic stents grafts market in Japan is set to experience positive growth. The country is likely to register a 4.5% CAGR from 2023 to 2033.

Japan has one of the world's most rapidly aging populations. This demographic trend has contributed to a high incidence of aortic diseases, such as abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). As individuals age, they become more susceptible to these conditions, creating a substantial patient pool for aortic stents graft procedures.

The preference for minimally invasive medical procedures has been on the rise in Japan. Aortic stents grafts offer a less invasive alternative to traditional open surgeries for aortic aneurysm repair. Patients and healthcare providers favor these procedures due to short recovery times and reduced post-operative complications.

Japan is renowned for its advanced medical technology and innovation. This extends to the field of aortic stents grafts, with ongoing developments in stents graft designs, materials, and customization options.

Patient-specific solutions, often created using cutting-edge technologies like 3D printing, are becoming more common, improving treatment outcomes.

Revolutionary Medical Technology to Propel the Market in Germany

The aortic stents graft market in Germany is characterized by a strong healthcare system that upholds rigorous standards and embraces cutting-edge medical technology. With an aging population, there is an increasing demand for aortic stents grafts, as advanced age is a significant risk factor for aortic diseases.

Minimally invasive endovascular procedures are preferred in Germany, with aortic stents grafts providing a less invasive alternative to traditional open surgeries. This approach leads to short patient recovery times and reduced post-operative complications.

Germany is a leader in technological innovation within the healthcare sector, continually enhancing stents graft designs, materials, and customization options. These innovations contribute to the improved safety and effectiveness of aortic stents graft procedures.

The aortic stents grafts market in Germany is anticipated to rise at a 5.1% CAGR from 2023 to 2033. By the end of the said forecast period, a valuation of US$ 600 million is expected.

Category-wise Insights

The below table highlights how abdominal aortic stents graft is projected to lead the market in terms of materials, developing at 5.1% CAGR through 2033.

The hospitals segment is likely to spearhead sales based on source and is anticipated to witness a CAGR of 5.2% through 2033.

Category	CAGR from 2023 to 2033
Abdominal Aortic Stents Graft	5.1%
Hospitals	5.2%

Larger Patient Pool to Drive the Abdominal Aortic Stents Graft Growth

The abdominal aortic stents graft segment is expected to rise at a CAGR of 5.1% from 2023 to 2033.

According to the market analysis, the abdominal aortic stents graft segment is predicted to rule the aortic stents grafts industry with a whopping 92% share by 2023. Expanding aortic stents graft sales are related to a larger patient pool with abdominal aortic aneurysms and high blood pressure, a bad lifestyle, and habitual smoking.

The most widespread sort of aneurysm in males aged over 65 is abdominal aortic aneurysm (AAA). It happens in the aorta that goes through the abdomen. Delayed or negligent treatment might have catastrophic repercussions, including death. Every year, an enormous number of endovascular repair operations are conducted.

Hospitals Segment to Dominate the Market

In terms of end users, hospitals are projected to lead the aortic stents grafts market, generating the lion's share of profit over the projected time frame. A CAGR of 5.2% is projected from 2023 to 2033.

Certain factors boosting demand for aortic stents graft systems include an increase in the sheer number of hospitals globally and increased government expenditures in building superior medical care. Due to a dearth of reimbursement rules and limited disposable cash in underdeveloped countries, people tend to seek treatment in hospitals.

Competitive Landscape

Leading competitors in the aortic stents grafts market are heavily spending on studies and development. Aside from that, they are dominating the industry through various growth tactics including alliances, purchases, partnerships, and innovative product releases and authorizations.

Endologix LLC declared in October 2022 that it’s ELEVATE (Expanding Patient Applicability with Polymer Sealing Ovation ALTO Stents Graft) IDE study had been released digitally in the Journal of Vascular Surgery. The research described the medical results of the ALTO abdominal stents graft system, emphasizing the device's security and reliability one year after surgery.
The company gained CE Mark Certification for its AFX2 Endovascular AAA System in August 2022 under the newly enacted EU Medical Devices Regulation. To treat a wide range of anatomies, the AFX endovascular AAA method combines anatomical fixation with a sophisticated delivery method and graft material innovation.

Report Scope

Attributes	Details
Estimated Market Size in 2023	US$ 2.5 billion
Projected Market Valuation in 2033	US$ 4.2 billion
Value-based CAGR 2023 to 2033	5%
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	Value in US$ billion
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa
Key Market Segments Covered	Product Type End User Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Cook Medical, Inc. W.L. Gore & Associates MicroPort Scientific Corporation Inc. Medtronic Plc. Lombard Medical, Inc. Endologix, INC. Terumo Corporation Inc. Cardinal Health Inc. Becton, Dickinson and Company Cryolife Inc.

Segmentation Analysis of the Aortic Stents Grafts Market

Product Type:

Abdominal Aortic Stents Graft
Thoracic Aortic Stents Graft

End User:

Hospitals
Ambulatory Surgical Centers/Outpatient Surgical Centers

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa

Frequently Asked Questions

What is the Expected Worth of the Aortic Stents Grafts Market in 2023?

The aortic stents grafts market is expected to reach US$ 2.5 billion in 2023.

What is the Growth Forecast for the Aortic Stents Grafts Market through 2033?

The market for aortic stents grafts is set to expand by a CAGR of 5% by 2033.

How much Valuation is Projected for the Aortic Stents Grafts Market in 2033?

The aortic stents grafts industry is expected to reach US$ 4.2 billion by 2033.

Which Country is Likely to be at the Pinnacle of the Aortic Stents Grafts Market?

China is likely to be the top-performing market, accounting for US$ 512 million in 2033.

Which is the Leading End User in the Aortic Stents Grafts Market?

The hospital segment is expected to rise at a 5.2% CAGR through 2033.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Abdominal
5.3.2. Thoracic
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers/Outpatient Surgical Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product Type
15.5.2.2. By End User
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Cook Medical, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. W.L. Gore & Associates
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. MicroPort Scientific Corporation Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Medtronic Plc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Lombard Medical, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Endologix, INC.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Terumo Corporation Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Cardinal Health Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Becton, Dickinson and Company
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Cryolife Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Aortic Stents Grafts Market

Aortic Stents Grafts Market Analysis by Abdominal Aortic Stents Graft, and Thoracic Aortic Stents Graft for 2023 to 2033